Evidity Health Capital
Growth equityNew York · Growth–Late Stage · 5 people tracked
Also known as EVIDITY CAPITAL LLC
Find your way into Evidity Health Capital
2,174 people in our graph share verified history with the Evidity Health Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Evidity Health Capital is a late-stage venture capital and growth equity firm focused on the healthcare sector, specializing in medical devices, in vitro diagnostics, and disruptive digital health. The firm targets private companies that already have commercialized products and need growth capital to reach profitability. Its approach is described as value-focused, evidence-based, and business-building, aiming to support innovative and transformative healthcare businesses. The firm was previously known as Canepa Healthcare and is led by three investment partners with complementary skillsets and a shared background and approach.
Source: firm website, verified Sep 15, 2026.
Team · 5 people
from public directories
What they invest in
from 14 of 16 portfolio companiesHealthtech ×12Medical Devices ×9Biotech ×6AI & Machine Learning ×3Hardware ×3Digital Health ×2Gaming ×1
HQs:United States×11
Investments · 16 tracked
founders shown can be your intro pathBy year:2026 · 12022 · 12021 · 12020 · 22018 · 12016 · 17 dated
Poseidon Medical develops a medical device technology intended to treat patients with critical limb ischemia (CLI) and help avoid amputation.
HealthtechMedical DevicesPembroke Pines, US
Richard Davis(Founder & CEO)inH. Richard Davis(Founder)inJohn Vacha(Chief Financial Officer)inHorace Richard Davis(Executive Officer)
BiotechIrvine, US
Alan Waterhouse(President and Chief Operating Officer)Jason Tester(Chief Financial Officer and Secretary)James V. Mazzo(President, Chief Executive Officer and Chairman of the Board)
BoardArjun Arora(Director)Richard L. Lindstrom, M.D.(Director)William J. Link(Director)
Co-investorsFlying L PartnersHEALTHCARE ROYALTY PARTNERSSV Life SciencesVersant Venture AIV HoldingsVersant Ventures
Akili Interactive develops digital therapeutics that use video game-based interventions to target attentional control deficits in patients with ADHD, delivered through proprietary technology featuring adaptive difficulty algorithms.
AI & Machine LearningDigital HealthGamingHealthtechMedical Devices
Co-investorsDG Daiwa VenturesJAZZ Venture PartnersMachina VenturesWalnut Venture AssociatesM Ventures
Augmedics develops augmented reality surgical navigation technology aimed at improving outcomes in spine surgery.
HardwareHealthtechMedical DevicesArlington Heights, US
Nissan Elimelech(Chief Executive Officer)in
Co-investorsAlmeda VenturesH.I.G. CapitalH.I.G. HealthBridge PartnersPartners ResoluteXR Invest
Biotheranostics develops proprietary genomic assays used to support personalized disease management in oncology.
BiotechHealthtechMedical DevicesSan Diego, US
Nicholas Barthelemy(Executive Officer, Director, Promoter)
BoardDavid Kabakoff(Director)inEric Bednarski(Director)Alejandro Sanchez(Director)in
Co-investorsHealthQuest CapitalMVM Life Science Partners
Cardiva Medical, part of Haemonetics, develops the VASCADE family of vascular closure systems, including venous and arterial closure devices used in cardiovascular procedures.
HardwareHealthtechMedical DevicesSanta Clara, US
George Lee(Director)Lisa Garrett(Executive Officer)Michael Bornitz(Director)Rick Anderson(Director)John Russell(Executive Officer, Director)Augustine Lien(Director)
Co-investorsEssex Woodlands Healthcare PartnersLuther King Capital ManagementPTV Healthcare Capital
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.
BiotechHealthtechMedical DevicesSan Mateo, US
Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)in
BoardMichael Carusi(Director)inArda Minocherhomjee(Director)
Co-investorsAccelmed PartnersCanaan PartnersLightstone VenturesVCFA GroupDe Novo VenturesFOUNDATION MEDICAL PARTNERS+1 more
GT Medical Technologies develops GammaTile, an implantable radiation therapy device for treating operable brain tumors.
BiotechHealthtechMedical Devices
Co-investorsAccelmed PartnersBlueStone Venture PartnersFemHealth Ventures
Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems.
HardwareHealthtechMedical DevicesSeattle, US
Gregory J Bullington(Executive Officer, Director)Richard Patton(Co-founder)
BoardPaul Meister(Director)
Co-investorsLauder PartnersRhapsody Venture PartnersVivo CapitalHealthQuest CapitalJanus Henderson InvestorsRTW Investments L.P.+2 more
PreludeDx develops precision diagnostic tests for breast cancer to help physicians make informed treatment decisions and improve patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesNashville, US
Troy Bremer(Co-founder & Chief Scientific Officer)Daniel Forche(President & CEO)
Co-investorsFjord VenturesBlueStone Venture Partners
Sonde develops voice-based biomarker technology to detect health conditions early through analysis of speech patterns on everyday devices.
AI & Machine LearningDigital HealthHealthtech
David Liu(Chief Executive Officer)inJames Harper(Chief Strategy Officer)inYogendra Jain(Chief Technology Officer)inErik Larsen(Senior Vice President, Clinical Development & Customer Success)inSanjay Pothen(Chief Financial Officer)Garrett Bussiere(Vice President of Strategic Partnerships)in
Co-investorsMC Healthcare VenturesM Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Akili Interactive LabsDune Medical DevicesDunemedicalGT Medical TechnologiesStandard Molecular
Portfolio news
latest coverage across their companiesMagnolia Medical Technologies · nasdaqprivatemarket.com · Oct 21, 2025
Frequently asked questions
- How many investments has Evidity Health Capital made?
- Evidity Health Capital has 16 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Evidity Health Capital invest at?
- Evidity Health Capital invests at the Growth, Late Stage stages.
- What is Evidity Health Capital's typical check size?
- Evidity Health Capital typically writes checks of $5M.
- What sectors does Evidity Health Capital focus on?
- Evidity Health Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Evidity Health Capital located?
- Evidity Health Capital is headquartered in New York, US.
- Who does Evidity Health Capital co-invest with?
- Evidity Health Capital most often shares deals with Accelmed Partners, BlueStone Venture Partners, Canaan Partners, among 21 tracked co-investors.
Images
Similar investors
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.